CALCITAT® C 50

Description

Solution for Injection
RECHARGE IN A SINGLE BREATH!

MAIN ADVANTAGES:
• Highly active calcium salts for rapid and effective action.
• Flexible use for individual treatment (IV, IM, SC).
• High quality standard in compliance with GMP requirements.

COMPOSITION:
100 ml of the product contains the following active substances:

• • Calcium gluconate monohydrate — 3.1 g
    • Calcium borogluconate — 42.9 g
    • Calcium hydroxide — 1.32 g
    • Magnesium chloride hexahydrate — 6.5 g
    • 2-aminoethyl dihydrogen phosphate — 0.6 g
    (equivalent to 4.56 g of calcium, 0.78 g of magnesium, and 0.132 g of phosphorus)

INDICATIONS FOR USE:
For treatment and prevention in animals:

• • Tetany (during pregnancy, lactation, transportation, grazing, etc.).
    • Paresis caused by calcium and phosphorus deficiency.
    • Disorders of calcium, phosphorus, and magnesium metabolism (rickets, osteodystrophy, osteomalacia, etc.).
    • Poisoning with lead, fluorine, or oxalic acid (as an adjunct in комплекс treatment).
    • Toxicosis, allergies.

DOSAGE AND ADMINISTRATION:

Injections are administered intravenously, intramuscularly, or subcutaneously:

• • Cattle:
    o Treatment of acute calcium deficiency and postpartum hypocalcemia — 200–220 ml per 500 kg body weight.
    o Prevention of calcium, phosphorus, and magnesium metabolism disorders — 100–150 ml per 500 kg body weight.
  • Calves, young cattle, sheep, goats, swine:
    o 15 ml per 50 kg body weight.
  • Piglets:
    o 1.5 ml per 5 kg body weight.
  • Dogs:
    o 2 ml per 10 kg body weight.
  • Cats:
    o 0.5 ml per 2.5 kg body weight.

Repeat administration:
• If necessary, the product may be administered again 6–8 hours after the first injection.

ADVERSE REACTIONS:
• No adverse effects have been observed when used correctly. However, tachycardia and cardiovascular disturbances may occur in cases of rapid administration.

CONTRAINDICATIONS:
• Do not use in cases of hypercalcemia, acidosis, cardiovascular disorders, renal insufficiency, or atrial fibrillation.
• Do not use in animals with hypersensitivity to the components of the product.

SPECIAL INSTRUCTIONS:
• Do not use simultaneously with digitalis preparations, vitamin D, or its analogues.
• Monitor heart rate and cardiac rhythm during administration.

STORAGE:
• Store in a dry place protected from light at a temperature from 0°C to +30°C.

SHELF LIFE:
• 3 years from the date of manufacture.
• After first opening of the vial — 28 days.

PRESENTATION:
• 250 ml and 500 ml vials — polypropylene bottles.
• 100 ml vials — glass bottles.